Illumina, Inc. Announces Participation in the 1000 Genomes Project

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc., (NASDAQ:ILMN) today announced that it is among three firms to have pioneered the development of new sequencing technologies and joined the 1000 Genomes Project, an international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Illumina Inc., San Diego, Calif.; 454 Life Sciences, a Roche company, Branford, Conn.; and Applied Biosystems, an Applera Corp. business, Foster City, Calif.

Back to news